Nucleus Genomics

📍 New York, United States🗓 Founded 2021👥 35 employees💰 Last funded 2025
Biotechnology🌐 mynucleus.com
Website LinkedIn
Nucleus is an advanced DNA health test that takes the guesswork out of healthcare, whether it’s knowing your risk for cancer or planning for a healthy family. Genomic testing has always been fragmented— there are over 70,000 genetic tests on the market today, each analyzing different genes or markers. Our technology combines all these tests into one to analyze your risk for over 800 conditions with a single swab. Knowledge is power. We deliver the insights you need to take action and live healthier, longer.
4
Total investors
0
Early stage
4
Mid stage
0
Late stage
2021
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2024–2025 · investors recorded per year
2024320251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Nucleus Genomics?
Nucleus Genomics has 4 investors on record on gritt.io, 4 mid-stage.
When did Nucleus Genomics last raise funding?
The most recent investment in Nucleus Genomics recorded on gritt.io was in 2025.
When was Nucleus Genomics founded?
Nucleus Genomics was founded in 2021.
What industry is Nucleus Genomics in?
Nucleus Genomics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Nucleus Genomics based?
Nucleus Genomics is headquartered in New York, United States.